Terms: = Colorectal cancer AND SEPT9, PNUTL4, 10801, ENSG00000184640, MSF1, KIAA0991, AF17q25, MSF, SeptD1, SINT1 AND Treatment
16 results:
1. Circulating-tumour DNA methylation of HAND1 gene: a promising biomarker in early detection of colorectal cancer.
Shavali M; Moradi A; Tahmaseb M; Mohammadian K; Ganji SM
BMC Med Genomics; 2024 Apr; 17(1):117. PubMed ID: 38689296
[TBL] [Abstract] [Full Text] [Related]
2. DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer.
Müller D; Győrffy B
Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188722. PubMed ID: 35307512
[TBL] [Abstract] [Full Text] [Related]
3. Application of droplet digital polymerase chain reaction of plasma methylated septin 9 on detection and early monitoring of colorectal cancer.
Ma ZY; Chan CSY; Lau KS; Ng L; Cheng YY; Leung WK
Sci Rep; 2021 Dec; 11(1):23446. PubMed ID: 34873218
[TBL] [Abstract] [Full Text] [Related]
4. msept9 Can Monitor the Response and Predict the Prognosis of Stage IV colorectal cancer Patients with Liver Metastasis Undergoing Potentially Curative Surgery.
Liu W; Hu P; Liu J; Chen L
J Surg Res; 2021 Nov; 267():485-494. PubMed ID: 34246842
[TBL] [Abstract] [Full Text] [Related]
5. [Relationship of DNMT3b expression and sept9 methylation in theprogression of colorectal carcinogenesis].
He N; Feng G; Dou JH; Tang GB; Qian MR; Chen L; Wu KC
Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):925-930. PubMed ID: 33256303
[No Abstract] [Full Text] [Related]
6. Detection of Methylated sept9 in Korean colorectal cancer Patients: Comparison with Previous Studies.
Kim H; Lee JK; Hong YJ; Moon SM; Shin US; Kwon H; Shin K; Chang YH
Clin Lab; 2018 Sep; 64(9):1573-1579. PubMed ID: 30273999
[TBL] [Abstract] [Full Text] [Related]
7. Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for colorectal cancer Liver Metastasis.
Bhangu JS; Beer A; Mittlböck M; Tamandl D; Pulverer W; Schönthaler S; Taghizadeh H; Stremitzer S; Kaczirek K; Gruenberger T; Gnant M; Bergmann M; Mannhalter C; Weinhäusel A; Oehler R; Bachleitner-Hofmann T
Ann Surg; 2018 Nov; 268(5):894-902. PubMed ID: 30080722
[TBL] [Abstract] [Full Text] [Related]
8. Potential of quantitative sept9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.
Bergheim J; Semaan A; Gevensleben H; Groening S; Knoblich A; Dietrich J; Weber J; Kalff JC; Bootz F; Kristiansen G; Dietrich D
Br J Cancer; 2018 May; 118(9):1217-1228. PubMed ID: 29610456
[TBL] [Abstract] [Full Text] [Related]
9. Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study.
Schröck A; Leisse A; de Vos L; Gevensleben H; Dröge F; Franzen A; Wachendörfer M; Schröck F; Ellinger J; Teschke M; Wilhelm-Buchstab T; Landsberg J; Holdenrieder S; Hartmann G; Field JK; Bootz F; Kristiansen G; Dietrich D
Clin Chem; 2017 Jul; 63(7):1288-1296. PubMed ID: 28515105
[TBL] [Abstract] [Full Text] [Related]
10. DNA methylation based biomarkers in colorectal cancer: A systematic review.
Lam K; Pan K; Linnekamp JF; Medema JP; Kandimalla R
Biochim Biophys Acta; 2016 Aug; 1866(1):106-20. PubMed ID: 27385266
[TBL] [Abstract] [Full Text] [Related]
11. Detection of colorectal cancer by DNA methylation biomarker sept9: past, present and future.
Li Y; Song L; Gong Y; He B
Biomark Med; 2014; 8(5):755-69. PubMed ID: 25123042
[TBL] [Abstract] [Full Text] [Related]
12. A panel of genes methylated with high frequency in colorectal cancer.
Mitchell SM; Ross JP; Drew HR; Ho T; Brown GS; Saunders NF; Duesing KR; Buckley MJ; Dunne R; Beetson I; Rand KN; McEvoy A; Thomas ML; Baker RT; Wattchow DA; Young GP; Lockett TJ; Pedersen SK; Lapointe LC; Molloy PL
BMC Cancer; 2014 Jan; 14():54. PubMed ID: 24485021
[TBL] [Abstract] [Full Text] [Related]
13. [The new blood test bio-marker sept9 and colorectal carcinoma screening].
Beneš Z; Sedivcová M; Antoš Z; Kohout P; Puškárová G; Cerník M; Rozmahel M; Shánělová M; Dolina J; Hep A; Trubač M; Stehlík J; Vaněček T; Michal M; Simša J; Kala Z
Vnitr Lek; 2013 Nov; 59(11):971-6. PubMed ID: 24279440
[TBL] [Abstract] [Full Text] [Related]
14. Detection of methylated sept9 in plasma is a reliable screening method for both left- and right-sided colon cancers.
Tóth K; Sipos F; Kalmár A; Patai AV; Wichmann B; Stoehr R; Golcher H; Schellerer V; Tulassay Z; Molnár B
PLoS One; 2012; 7(9):e46000. PubMed ID: 23049919
[TBL] [Abstract] [Full Text] [Related]
15. [Hypermethylation of the CDH1, sept9, HLTF and ALX4 genes and their diagnostic significance in colorectal cancer].
Kostin PA; Zakharzhevskaia NB; Generozov EV; Govorun VM; Chernyshov SV; Shchelygin IuA
Vopr Onkol; 2010; 56(2):162-8. PubMed ID: 20552891
[TBL] [Abstract] [Full Text] [Related]
16. Recent patents and advances in genomic biomarker discovery for colorectal cancers.
Quyun C; Ye Z; Lin SC; Lin B
Recent Pat DNA Gene Seq; 2010 Jun; 4(2):86-93. PubMed ID: 20426761
[TBL] [Abstract] [Full Text] [Related]
